Business Description
Nova Mentis Life Science Corp
NAICS : 541714
SIC : 3741
ISIN : CA53069P1018
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.2 | |||||
Equity-to-Asset | -40.23 | |||||
Debt-to-Equity | -0.06 | |||||
Debt-to-EBITDA | -0.14 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -3344.02 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 28.3 | |||||
3-Year EPS without NRI Growth Rate | 27.7 | |||||
3-Year FCF Growth Rate | 25.9 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 54.07 | |||||
9-Day RSI | 50.56 | |||||
14-Day RSI | 49.18 | |||||
6-1 Month Momentum % | -56.52 | |||||
12-1 Month Momentum % | -75.43 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.01 | |||||
Quick Ratio | 0.01 | |||||
Cash Ratio | 0.01 | |||||
Days Sales Outstanding | 78.21 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -65.3 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -1528.57 | |||||
Net Margin % | -1496.43 | |||||
FCF Margin % | -171.43 | |||||
ROA % | -1047.5 | |||||
ROIC % | -839.22 | |||||
3-Year ROIIC % | 12.57 | |||||
ROC (Joel Greenblatt) % | -3890.91 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -1.8 | |||||
EV-to-EBITDA | -1.81 | |||||
EV-to-Revenue | 27 | |||||
EV-to-FCF | -16.12 | |||||
Earnings Yield (Greenblatt) % | -55.56 | |||||
FCF Yield % | -6.75 |